ID   CDK20_HUMAN             Reviewed;         346 AA.
AC   Q8IZL9; A2A389; A2A390; B4DQX1; O95137; Q5EDC4; Q5VYW1; Q9BUF4;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   12-OCT-2022, entry version 165.
DE   RecName: Full=Cyclin-dependent kinase 20;
DE            EC=2.7.11.22;
DE   AltName: Full=CDK-activating kinase p42;
DE            Short=CAK-kinase p42;
DE   AltName: Full=Cell cycle-related kinase;
DE   AltName: Full=Cell division protein kinase 20;
DE   AltName: Full=Cyclin-dependent protein kinase H;
DE   AltName: Full=Cyclin-kinase-activating kinase p42;
GN   Name=CDK20; Synonyms=CCRK, CDCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Jiang Y., Zhao K.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Chen J.H., Luo W.Q., Hu S.N., Huang X.W., Tan X.Y., Yuan J.G., Qiang B.Q.;
RT   "Cloning a cyclin-dependent protein kinase CDCH.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RA   Qiu H., Depre C.;
RT   "Cardiac CCRK splice variant.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-86; THR-137 AND
RP   ARG-281.
RG   NIEHS SNPs program;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF THR-161.
RX   PubMed=14597612; DOI=10.1074/jbc.m309995200;
RA   Liu Y., Wu C., Galaktionov K.;
RT   "p42, a novel cyclin-dependent kinase-activating kinase in mammalian
RT   cells.";
RL   J. Biol. Chem. 279:4507-4514(2004).
RN   [10]
RP   INTERACTION WITH MAK.
RX   PubMed=21986944; DOI=10.1038/onc.2011.464;
RA   Wang L.Y., Kung H.J.;
RT   "Male germ cell-associated kinase is overexpressed in prostate cancer cells
RT   and causes mitotic defects via deregulation of APC/C(CDH1).";
RL   Oncogene 31:2907-2918(2012).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-106.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required for high-level Shh responses in the developing
CC       neural tube. Together with TBC1D32, controls the structure of the
CC       primary cilium by coordinating assembly of the ciliary membrane and
CC       axoneme, allowing GLI2 to be properly activated in response to SHH
CC       signaling (By similarity). Involved in cell growth. Activates CDK2, a
CC       kinase involved in the control of the cell cycle, by phosphorylating
CC       residue 'Thr-160'. {ECO:0000250, ECO:0000269|PubMed:14597612}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.22;
CC   -!- SUBUNIT: Monomer. Interacts with TBC1D32 (By similarity). Interacts
CC       with MAK. {ECO:0000250, ECO:0000269|PubMed:14597612,
CC       ECO:0000269|PubMed:21986944}.
CC   -!- INTERACTION:
CC       Q8IZL9; Q9C040: TRIM2; NbExp=3; IntAct=EBI-6128565, EBI-749840;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14597612}. Cytoplasm
CC       {ECO:0000250}. Cell projection, cilium {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8IZL9-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cardiac CCRK;
CC         IsoId=Q8IZL9-2; Sequence=VSP_016748, VSP_016750;
CC       Name=3;
CC         IsoId=Q8IZL9-3; Sequence=VSP_016749, VSP_016751, VSP_016752;
CC       Name=4;
CC         IsoId=Q8IZL9-4; Sequence=VSP_043294, VSP_016749;
CC       Name=5;
CC         IsoId=Q8IZL9-5; Sequence=VSP_016749;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC98920.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ccrk/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CCRKID43196ch9q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF035013; AAC98920.1; ALT_FRAME; mRNA.
DR   EMBL; AF113130; AAF43778.1; -; mRNA.
DR   EMBL; AY904367; AAW82349.1; -; mRNA.
DR   EMBL; AF547664; AAN28684.1; -; Genomic_DNA.
DR   EMBL; AK075325; BAG52110.1; -; mRNA.
DR   EMBL; AK298993; BAG61083.1; -; mRNA.
DR   EMBL; AL353572; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471089; EAW62746.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62748.1; -; Genomic_DNA.
DR   EMBL; BC002655; AAH02655.1; -; mRNA.
DR   CCDS; CCDS35060.1; -. [Q8IZL9-1]
DR   CCDS; CCDS55324.1; -. [Q8IZL9-2]
DR   CCDS; CCDS65075.1; -. [Q8IZL9-3]
DR   CCDS; CCDS6677.1; -. [Q8IZL9-5]
DR   CCDS; CCDS6678.1; -. [Q8IZL9-4]
DR   RefSeq; NP_001034892.1; NM_001039803.2. [Q8IZL9-1]
DR   RefSeq; NP_001164110.1; NM_001170639.1. [Q8IZL9-3]
DR   RefSeq; NP_001164111.1; NM_001170640.1. [Q8IZL9-2]
DR   RefSeq; NP_036251.2; NM_012119.4. [Q8IZL9-5]
DR   RefSeq; NP_848519.1; NM_178432.3. [Q8IZL9-4]
DR   AlphaFoldDB; Q8IZL9; -.
DR   SMR; Q8IZL9; -.
DR   BioGRID; 117096; 116.
DR   IntAct; Q8IZL9; 43.
DR   STRING; 9606.ENSP00000322343; -.
DR   BindingDB; Q8IZL9; -.
DR   ChEMBL; CHEMBL3559690; -.
DR   GlyGen; Q8IZL9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8IZL9; -.
DR   PhosphoSitePlus; Q8IZL9; -.
DR   BioMuta; CDK20; -.
DR   DMDM; 74759739; -.
DR   EPD; Q8IZL9; -.
DR   jPOST; Q8IZL9; -.
DR   MassIVE; Q8IZL9; -.
DR   MaxQB; Q8IZL9; -.
DR   PaxDb; Q8IZL9; -.
DR   PeptideAtlas; Q8IZL9; -.
DR   PRIDE; Q8IZL9; -.
DR   ProteomicsDB; 71369; -. [Q8IZL9-1]
DR   ProteomicsDB; 71370; -. [Q8IZL9-2]
DR   ProteomicsDB; 71371; -. [Q8IZL9-3]
DR   ProteomicsDB; 71372; -. [Q8IZL9-4]
DR   Antibodypedia; 27918; 352 antibodies from 29 providers.
DR   DNASU; 23552; -.
DR   Ensembl; ENST00000325303.9; ENSP00000322343.8; ENSG00000156345.18. [Q8IZL9-1]
DR   Ensembl; ENST00000336654.9; ENSP00000338975.5; ENSG00000156345.18. [Q8IZL9-4]
DR   Ensembl; ENST00000375871.8; ENSP00000365031.3; ENSG00000156345.18. [Q8IZL9-2]
DR   Ensembl; ENST00000375883.7; ENSP00000365043.3; ENSG00000156345.18. [Q8IZL9-5]
DR   Ensembl; ENST00000605159.5; ENSP00000474485.1; ENSG00000156345.18. [Q8IZL9-3]
DR   GeneID; 23552; -.
DR   KEGG; hsa:23552; -.
DR   MANE-Select; ENST00000325303.9; ENSP00000322343.8; NM_001039803.3; NP_001034892.1.
DR   UCSC; uc004apr.4; human. [Q8IZL9-1]
DR   CTD; 23552; -.
DR   DisGeNET; 23552; -.
DR   GeneCards; CDK20; -.
DR   HGNC; HGNC:21420; CDK20.
DR   HPA; ENSG00000156345; Low tissue specificity.
DR   MalaCards; CDK20; -.
DR   MIM; 610076; gene.
DR   neXtProt; NX_Q8IZL9; -.
DR   OpenTargets; ENSG00000156345; -.
DR   PharmGKB; PA165585688; -.
DR   VEuPathDB; HostDB:ENSG00000156345; -.
DR   eggNOG; KOG0659; Eukaryota.
DR   GeneTree; ENSGT00940000159128; -.
DR   HOGENOM; CLU_000288_181_6_1; -.
DR   InParanoid; Q8IZL9; -.
DR   OMA; KITFPYH; -.
DR   OrthoDB; 1367115at2759; -.
DR   PhylomeDB; Q8IZL9; -.
DR   TreeFam; TF327240; -.
DR   PathwayCommons; Q8IZL9; -.
DR   SignaLink; Q8IZL9; -.
DR   SIGNOR; Q8IZL9; -.
DR   BioGRID-ORCS; 23552; 10 hits in 1105 CRISPR screens.
DR   ChiTaRS; CDK20; human.
DR   GenomeRNAi; 23552; -.
DR   Pharos; Q8IZL9; Tbio.
DR   PRO; PR:Q8IZL9; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q8IZL9; protein.
DR   Bgee; ENSG00000156345; Expressed in right uterine tube and 121 other tissues.
DR   ExpressionAtlas; Q8IZL9; baseline and differential.
DR   Genevisible; Q8IZL9; HS.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1990403; P:embryonic brain development; IEA:Ensembl.
DR   GO; GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0021508; P:floor plate formation; IEA:Ensembl.
DR   GO; GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0061512; P:protein localization to cilium; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:1903317; P:regulation of protein maturation; IEA:Ensembl.
DR   GO; GO:0060021; P:roof of mouth development; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cell projection; Cilium; Cytoplasm; Developmental protein; Kinase;
KW   Nucleotide-binding; Nucleus; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..346
FT                   /note="Cyclin-dependent kinase 20"
FT                   /id="PRO_0000085701"
FT   DOMAIN          4..288
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        127
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         25
FT                   /note="E -> EPRVGWQCLPSILQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043294"
FT   VAR_SEQ         168..243
FT                   /note="WYRAPELLYGARQYDQGVDLWSVGCIMGELLNGSPLFPGKNDIEQLCYVLRI
FT                   LGTPNPQVWPELTELPDYNKISFK -> SSLSCRTTTRSPLRSRCPCPWRRCCLTSLPR
FT                   HWICWVNSFSTLLTSASQLPRLSSISTSSQLPCLPIHLSCRFLSV (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_016748"
FT   VAR_SEQ         168..188
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1,
FT                   ECO:0000303|Ref.2"
FT                   /id="VSP_016749"
FT   VAR_SEQ         244..346
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_016750"
FT   VAR_SEQ         282..296
FT                   /note="ALLHQYFFTAPLPAH -> LPCLPIHLSCRFLSV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016751"
FT   VAR_SEQ         297..346
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016752"
FT   VARIANT         86
FT                   /note="S -> L (in dbSNP:rs28364953)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_024762"
FT   VARIANT         106
FT                   /note="S -> N (in dbSNP:rs41286029)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041957"
FT   VARIANT         137
FT                   /note="A -> T (in dbSNP:rs28364955)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_024763"
FT   VARIANT         281
FT                   /note="K -> R (in dbSNP:rs28364963)"
FT                   /evidence="ECO:0000269|Ref.4"
FT                   /id="VAR_024764"
FT   MUTAGEN         161
FT                   /note="T->A: Impairs CDK2 T-160 phosphorylation and
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:14597612"
FT   CONFLICT        30
FT                   /note="V -> I (in Ref. 1; AAC98920 and 2; AAF43778)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   346 AA;  38695 MW;  EB6A53E97301D5AE CRC64;
     MDQYCILGRI GEGAHGIVFK AKHVETGEIV ALKKVALRRL EDGFPNQALR EIKALQEMED
     NQYVVQLKAV FPHGGGFVLA FEFMLSDLAE VVRHAQRPLA QAQVKSYLQM LLKGVAFCHA
     NNIVHRDLKP ANLLISASGQ LKIADFGLAR VFSPDGSRLY THQVATRWYR APELLYGARQ
     YDQGVDLWSV GCIMGELLNG SPLFPGKNDI EQLCYVLRIL GTPNPQVWPE LTELPDYNKI
     SFKEQVPMPL EEVLPDVSPQ ALDLLGQFLL YPPHQRIAAS KALLHQYFFT APLPAHPSEL
     PIPQRLGGPA PKAHPGPPHI HDFHVDRPLE ESLLNPELIR PFILEG
//
